NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 203 filers reported holding NEVRO CORP in Q2 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $29,730,000 | -5.3% | 372,318 | +2.8% | 0.74% | -3.3% |
| Q1 2018 | $31,400,000 | +7.8% | 362,299 | -14.1% | 0.77% | +12.1% |
| Q4 2017 | $29,128,000 | +5.6% | 421,896 | +39.0% | 0.68% | +3.5% |
| Q3 2017 | $27,578,000 | +13.9% | 303,460 | -6.7% | 0.66% | +9.6% |
| Q2 2017 | $24,215,000 | -16.8% | 325,336 | +4.7% | 0.60% | -18.4% |
| Q1 2017 | $29,090,000 | +24.5% | 310,762 | -3.3% | 0.74% | +22.1% |
| Q4 2016 | $23,359,000 | -14.5% | 321,479 | +22.9% | 0.61% | -14.9% |
| Q3 2016 | $27,311,000 | – | 261,628 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |